BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15555563)

  • 1. Glucocorticoids decrease the bioavailability of TGF-beta which leads to a reduced TGF-beta signaling in hepatic stellate cells.
    Bolkenius U; Hahn D; Gressner AM; Breitkopf K; Dooley S; Wickert L
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1264-70. PubMed ID: 15555563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells.
    Zheng S; Chen A
    Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G113-23. PubMed ID: 16959952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture.
    Breitkopf K; Lahme B; Tag CG; Gressner AM
    Hepatology; 2001 Feb; 33(2):387-96. PubMed ID: 11172340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid receptors interfere with the TGF-beta/Smad signaling pathway in a ligand-specific manner.
    Pendaries V; Verrecchia F; Michel S; Mauviel A
    Oncogene; 2003 Nov; 22(50):8212-20. PubMed ID: 14603262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dexamethasone on the expression of transforming growth factor-beta in mouse embryonic palatal mesenchymal cells.
    Potchinsky M; Nugent P; Lafferty C; Greene RM
    J Cell Physiol; 1996 Feb; 166(2):380-6. PubMed ID: 8591998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads.
    Weng H; Mertens PR; Gressner AM; Dooley S
    J Hepatol; 2007 Feb; 46(2):295-303. PubMed ID: 17125875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.
    Javelaud D; Mauviel A
    Oncogene; 2005 Aug; 24(37):5742-50. PubMed ID: 16123807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
    Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
    Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acid-mediated thrombospondin-1 induction in hepatocytes leads to transforming growth factor-beta-dependent hepatic stellate cell activation.
    Myung SJ; Yoon JH; Gwak GY; Kim W; Yang JI; Lee SH; Jang JJ; Lee HS
    Biochem Biophys Res Commun; 2007 Feb; 353(4):1091-6. PubMed ID: 17204245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP.
    Cui Q; Lim SK; Zhao B; Hoffmann FM
    Oncogene; 2005 Jun; 24(24):3864-74. PubMed ID: 15750622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing.
    Schiller M; Javelaud D; Mauviel A
    J Dermatol Sci; 2004 Aug; 35(2):83-92. PubMed ID: 15265520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta/Smad signaling in the injured liver.
    Breitkopf K; Godoy P; Ciuclan L; Singer MV; Dooley S
    Z Gastroenterol; 2006 Jan; 44(1):57-66. PubMed ID: 16397841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth.
    O'Rear L; Longobardi L; Torello M; Law BK; Moses HL; Chiarelli F; Spagnoli A
    J Mol Endocrinol; 2005 Jun; 34(3):723-37. PubMed ID: 15956343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression pattern.
    Ruehl M; Erben U; Kim K; Freise C; Dagdelen T; Eisele S; Trowitzsch-Kienast W; Zeitz M; Jia J; Stickel F; Somasundaram R
    J Nutr Biochem; 2009 Aug; 20(8):597-606. PubMed ID: 18824344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling.
    Yu Z; Xing Y
    Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyl-L-cysteine suppresses TGF-beta signaling at distinct molecular steps: the biochemical and biological efficacy of a multifunctional, antifibrotic drug.
    Meurer SK; Lahme B; Tihaa L; Weiskirchen R; Gressner AM
    Biochem Pharmacol; 2005 Oct; 70(7):1026-34. PubMed ID: 16098950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta induces novel Lef-1 splice variants through a Smad-independent signaling pathway.
    Cordray P; Satterwhite DJ
    Dev Dyn; 2005 Apr; 232(4):969-78. PubMed ID: 15736165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta and Smad signalling in kidney diseases.
    Wang W; Koka V; Lan HY
    Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts.
    Liu X; Sun SQ; Hassid A; Ostrom RS
    Mol Pharmacol; 2006 Dec; 70(6):1992-2003. PubMed ID: 16959941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway.
    Santander C; Brandan E
    Cell Signal; 2006 Sep; 18(9):1482-91. PubMed ID: 16413747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.